Precision Medicine in Action: New Blood Test May Predict Lupus Flares, Eliminate Treatment Trial and Error
AMPEL BioSolutions’ LuGENE blood test may help predict lupus flares and drug targets from gene expression utilizing predictive artificial intelligence (AI). The blood test measures RNA gene expression to predicts flares before they happen and provides specific information about a patient’s disease abnormalities, allowing physicians to make evidence-based decisions regarding therapy. AMPEL’s RNA blood or […]